In our study, the combination treatment (GRg5 with PTX) induced significant cell death in cervical cancer cells and appeared to be mediated by the downregulation of the Akt pathway along with the downregulation of the IKK-α /NF-κB pathway. The gene discussed is NFKB1; the disease is cervical carcinoma.